Announcements Trials

Browse Landscape

Phase

Phase NA 18 Phase 3 2 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3 Breast 3 Gastrointestinal 2 Other hematologic neoplasm 1 Gynecologic 1 Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 413 Cytarabine 336 fludarabine phosphate 231 Rituximab 206 Methotrexate 198 fludarabine 195 venetoclax 174 Azacitidine 174 Busulfan 169 Filgrastim 145 Whole-Body Irradiation 143 Mycophenolic Acid 143 Peripheral Blood Stem Cell Transplantation 141 Tacrolimus 138 Etoposide 130 Vincristine 112 Melphalan 110 Dexamethasone 109 Cyclosporine 102 Granulocyte Colony-Stimulating Factor 100 Imatinib Mesylate 94 Antilymphocyte Serum 91 Daunorubicin 90 Radiotherapy 84 Decitabine 83 Dasatinib 76 Lenalidomide 75 Doxorubicin 70 Prednisone 68 Idarubicin 68

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Methods × Other hematologic neoplasm × Clear all

NCT07507825 2026-04-02

VHAG

First People's Hospital of Hangzhou

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡